FR16C1025I1 - 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile salt - Google Patents
4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile saltInfo
- Publication number
- FR16C1025I1 FR16C1025I1 FR16C1025C FR16C1025C FR16C1025I1 FR 16C1025 I1 FR16C1025 I1 FR 16C1025I1 FR 16C1025 C FR16C1025 C FR 16C1025C FR 16C1025 C FR16C1025 C FR 16C1025C FR 16C1025 I1 FR16C1025 I1 FR 16C1025I1
- Authority
- FR
- France
- Prior art keywords
- amino
- cyanoethenyl
- dimethylphenyl
- pyrimidinyl
- benzonitrile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Abstract
The present invention relates to a pharmaceutical composition comprising as active ingredient the hydrochloric acid salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile and to processes for their preparation.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI20043578A MY169670A (en) | 2003-09-03 | 2004-09-02 | Combinations of a pyrimidine containing nnrti with rt inhibitors |
PCT/EP2004/052028 WO2005021001A1 (en) | 2003-09-03 | 2004-09-03 | Combinations of a pyrimidine containing nnrti with rt inhibitors |
EP05101467 | 2005-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
FR16C1025I1 true FR16C1025I1 (en) | 2017-02-03 |
Family
ID=38091637
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR16C1025C Active FR16C1025I1 (en) | 2004-09-02 | 2016-12-20 | 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile salt |
FR16C1023C Active FR16C1023I1 (en) | 2004-09-02 | 2016-12-20 | 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile salt |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR16C1023C Active FR16C1023I1 (en) | 2004-09-02 | 2016-12-20 | 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile salt |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1632232B3 (en) |
JP (1) | JP4912309B2 (en) |
CN (1) | CN104586850A (en) |
AT (1) | ATE508748T1 (en) |
BR (1) | BRPI0514871A (en) |
CY (3) | CY1112249T1 (en) |
DK (1) | DK1632232T6 (en) |
EA (1) | EA013686B1 (en) |
ES (1) | ES2371442T7 (en) |
FR (2) | FR16C1025I1 (en) |
HK (1) | HK1210029A1 (en) |
HU (2) | HUS1600060I1 (en) |
IL (1) | IL181650A (en) |
LT (2) | LTPA2016043I1 (en) |
ME (1) | ME01246B (en) |
MX (1) | MX2007002595A (en) |
NI (1) | NI200700068A (en) |
NO (3) | NO340654B1 (en) |
PT (1) | PT1632232E (en) |
RS (1) | RS51923B2 (en) |
SI (1) | SI1632232T1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY169670A (en) | 2003-09-03 | 2019-05-08 | Tibotec Pharm Ltd | Combinations of a pyrimidine containing nnrti with rt inhibitors |
NZ569347A (en) | 2006-01-20 | 2011-07-29 | Tibotec Pharm Ltd | Long term treatment of HIV-infection with 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
TWI494133B (en) | 2007-03-14 | 2015-08-01 | Tibotec Pharm Ltd | Powders for reconstitution |
PE20211657A1 (en) | 2010-11-19 | 2021-08-24 | Gilead Sciences Inc | THERAPEUTIC COMPOSITIONS INCLUDING RILPIVIRIN HCL AND TENOFOVIR DISOPROXIL FUMARATE |
BR112013016546A2 (en) * | 2011-04-15 | 2016-09-27 | Emcure Pharmaceuticals Ltd | process for rilpivirine improvement |
EP2604593A1 (en) | 2011-12-14 | 2013-06-19 | Sandoz AG | Polymorph of Rilpivirine hydrochloride and its use as antiviral |
WO2013087794A1 (en) | 2011-12-14 | 2013-06-20 | Sandoz Ag | Polymorph of rilpivirine hydrochloride and its use as antiviral |
EP2628732A1 (en) * | 2012-02-20 | 2013-08-21 | Sandoz AG | Novel crystalline form of rilpivirine hydrochloride |
WO2013153162A1 (en) * | 2012-04-11 | 2013-10-17 | Sandoz Ag | Polymorph of rilpivirine hydrochloride |
WO2013153161A2 (en) * | 2012-04-11 | 2013-10-17 | Sandoz Ag | Novel polymorph of rilpivirine hydrochloride |
CN103570688B (en) * | 2012-07-19 | 2016-06-08 | 中国科学院上海药物研究所 | 2,5-diaminomethyl pyrazine compounds, its pharmaceutical composition, preparation method and purposes |
GR1008965B (en) * | 2015-12-02 | 2017-02-28 | Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων | Pharmaceutical darunavir-containing formulation - preparation method thereof |
RU2616267C1 (en) * | 2016-01-25 | 2017-04-13 | Закрытое Акционерное Общество "БИОКОМ" | Solid drug form of indinavir with immediate release and method of obtaining thereof |
HRP20240118T1 (en) * | 2016-10-24 | 2024-04-12 | Janssen Sciences Ireland Unlimited Company | Dispersible compositions |
CN114392241B (en) * | 2022-01-10 | 2023-07-25 | 安徽贝克生物制药有限公司 | Ripide Wei Linpian and preparation method thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6307543B1 (en) * | 1998-09-10 | 2001-10-23 | Silicon Image, Inc. | Bi-directional data transfer using two pair of differential lines as a single additional differential pair |
MY169670A (en) * | 2003-09-03 | 2019-05-08 | Tibotec Pharm Ltd | Combinations of a pyrimidine containing nnrti with rt inhibitors |
JO3429B1 (en) * | 2001-08-13 | 2019-10-20 | Janssen Pharmaceutica Nv | Hiv inhibiting pyrimidines derivatives |
NZ538611A (en) * | 2002-08-09 | 2007-03-30 | Janssen Pharmaceutica Nv | Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
WO2004050068A1 (en) * | 2002-11-29 | 2004-06-17 | Janssen Pharmaceutica N.V. | Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
CL2004000192A1 (en) * | 2003-02-07 | 2005-03-18 | Janssen Pharmaceutica Nv | USE OF COMPOUNDS DERIVED FROM 2-AMINOPIRIMIDINE TO PREPARE A MEDICINAL PRODUCT FOR THE PREVENTION OF HIV INFECTION SEXUAL RELATIONS OR AN INTIMATE COUPLE CONTACT. |
-
2005
- 2005-09-02 ME MEP-2011-144A patent/ME01246B/en unknown
- 2005-09-02 JP JP2007528886A patent/JP4912309B2/en active Active
- 2005-09-02 RS RS20110355A patent/RS51923B2/en unknown
- 2005-09-02 SI SI200531339T patent/SI1632232T1/en unknown
- 2005-09-02 ES ES05108086T patent/ES2371442T7/en active Active
- 2005-09-02 DK DK05108086.9T patent/DK1632232T6/en active
- 2005-09-02 BR BRPI0514871-5A patent/BRPI0514871A/en not_active Application Discontinuation
- 2005-09-02 AT AT05108086T patent/ATE508748T1/en active
- 2005-09-02 EA EA200700536A patent/EA013686B1/en active Protection Beyond IP Right Term
- 2005-09-02 CN CN201510012919.7A patent/CN104586850A/en active Pending
- 2005-09-02 EP EP05108086.9A patent/EP1632232B3/en active Active
- 2005-09-02 MX MX2007002595A patent/MX2007002595A/en active IP Right Grant
- 2005-09-02 PT PT05108086T patent/PT1632232E/en unknown
-
2007
- 2007-03-01 NI NI200700068A patent/NI200700068A/en unknown
- 2007-03-01 IL IL181650A patent/IL181650A/en active IP Right Grant
- 2007-04-02 NO NO20071745A patent/NO340654B1/en active Protection Beyond IP Right Term
-
2011
- 2011-08-10 CY CY20111100775T patent/CY1112249T1/en unknown
-
2015
- 2015-11-03 HK HK15110805.7A patent/HK1210029A1/en unknown
-
2016
- 2016-12-20 HU HUS1600060C patent/HUS1600060I1/en unknown
- 2016-12-20 FR FR16C1025C patent/FR16C1025I1/en active Active
- 2016-12-20 HU HUS1600061C patent/HUS1600061I1/en unknown
- 2016-12-20 FR FR16C1023C patent/FR16C1023I1/en active Active
- 2016-12-20 CY CY2016051C patent/CY2016051I1/en unknown
- 2016-12-20 LT LTPA2016043C patent/LTPA2016043I1/en unknown
- 2016-12-20 LT LTPA2016042C patent/LTPA2016042I1/en unknown
- 2016-12-20 CY CY2016050C patent/CY2016050I1/en unknown
-
2017
- 2017-11-21 NO NO2017065C patent/NO2017065I1/en unknown
- 2017-11-21 NO NO2017063C patent/NO2017063I1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR16C1025I1 (en) | 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile salt | |
HK1174922A1 (en) | Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6- dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile 4-[[4-[[4-(2-)-2,6-]]-2-]] | |
ME00191B (en) | Pharmaceutical compositions comprising a hmg coa reductase inhibitor | |
PL1632232T6 (en) | Salt of 4[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile | |
WO2009007441A3 (en) | Crystalline form of (e) 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile | |
UA92467C2 (en) | Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl] amino]benzonitrile | |
CR9032A (en) | 4 - ((4 - ((4- (2-CYANETHETHYL)) -2,6-DIMETHYLPHENYL) AMINO-2- PYRIMIDINYL) AMINO) BENZONITRILE FUMARATE | |
WO2010030201A3 (en) | Stable oral pharmaceutical composition containing a pharmaceutically acceptable salt of [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrimidine-5-yl] (3r, 5s) - 3,5 dihydroxyhept-6- enoic acid | |
AP2487A (en) | Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile | |
HRP20110563T1 (en) | Salt of 4[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |